Lung Cancer Small Cell Symptoms Wellsphere Listofhighproteinfoods - Articles

Sort by: Newest Most Comments Relevance

Small cell lung cancer (S ... by Mark Levin Posted Tue 19 Jul 2011 10:11am Small cell lung cancer (SCLC) is different and distinct from other lung cancers, called non–small-cell lung cancers (NSCLCs), because SCLC exhibits aggressive behavior... reports a phase II trial in patients with previously-treated small cell carcinoma of the lung. 34 patients received 100 mg/m2 of docetaxel in an intravenous infusion given over 1 h Read on »

Gefitinib for Non-Small Cell Lung Cancer Trial by Cancer.gov Posted Tue 22 Feb 2011 11:14pm ... Read on »

Chemotherapy and Twice-Daily Radiation Improves Small Cell Lung Cancer Survival by Cancer.gov Posted Tue 22 Feb 2011 11:11pm ... Read on »

Single agent Taxol for relapsed small cell lung cancer by Mark Levin Posted Fri 28 May 2010 4:10pm Small cell lung cancer that progresses after first line chemotherapy has a poor prognosis. A variety of treatments are available, among them single agent Taxol.The... small cell lung cancer.Anticancer Res. 2006 Jan-Feb;26(1B):777-81. Graziano SL, Herndon JE 2nd, Socinski MA, Wang X, Watson D, Vokes E, Green MR; Cancer and Leukemia Group Read on »

Etoposide and carboplatin for small cell lung cancer by Mark Levin Posted Thu 09 Feb 2012 2:54am Standard treatment for patients with extensive SCLC include VePesid® (etoposide) plus Platinol, VePesid plus Paraplatin or Camptosar® (irinotecan) plus Platinol. Etoposide and carboplatin is standard chemotherapy, which is supported by the NCCN guideline. VePesid (etoposide) Capsules in combination with other approved chemotherapeutic agents ... Read on »

Amrubicin for small cell lung cancer by Mark Levin Posted Wed 24 Jun 2009 7:01pm product designation by the U.S. Food and Drug Administration (FDA) for the treatment of small cell lung cancer after first-line chemotherapy. Amrubicin is being studied in clicnal... Amrubicin, previously known as SM-5887, is an anthracycline used in the treatment of lung cancer. It is marketed in Japan since 2002 by Sumitomo Pharmaceuticals under Read on »

New therapeutic approaches for small cell lung cancer by Mark Pool, MD Posted Sun 13 Dec 2009 12:00am . Hurwitz J, McCoy F, Scullin P, Fennell D. New advances in the second-line treatment of small cell lung cancer. Oncologist. 2009;14(10):986-994. ... I am currently working on a project with our lung cancer research group at Rush University Medical Center in Chicago in which we are looking at expression Read on »

Gemcitaibne for non-small cell lung cancer in second line by Mark Levin Posted Fri 08 Apr 2011 1:59pm on the role of gemcitabine: Use of Gemcitabine in Non-Small Cell Lung Cancer Practice Guideline Report # 7-8 (Version 2.2002) by Ellis P, Mackay JA, Evans WK, and the Lung Cancer... cell lung cancer, Use of Gemcitabine in Non-Small Cell Lung Cancer Practice Guideline Report # 7-8 (Version 2.2002) by Ellis P, Mackay JA, Evans WK, and the Lung Cancer Disease Read on »

Non-small Cell Lung Cancer by LungHealth .. Posted Sun 24 Aug 2008 1:49pm . AZZOLI, MD: The most common form of lung cancer is called non-small cell lung cancer. About 15 percent of lung cancer is small cell lung cancer. ANNOUNCER: Lung cancers don't tend to stay put. They often tend to spread, and how they do so is the basis of a system of staging. CHRISTOPHER G. AZZOLI, MD: Non-small cell lung cancer starts in the lung Read on »

Abraxane caroplatin for non-small cell lung cancer by Mark Levin Posted Sun 27 Feb 2011 1:57pm al. Phase I/II study of ABI-007 as first line chemotherapy in advanced non-small cell lung cancer. J Clin Oncol 2006;24:Abstract # 7105. Green MR, Manikhas GM, Orlov S, et al. Abraxane, a novel Cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer. Ann Oncol 2006;17:1263-1268. Hawkins MJ Read on »